ACT Capital Management »

Nuvation Bio shares owned by ACT Capital Management

Quarter-by-quarter ownership of Nuvation Bio (NUVB) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Nuvation Bio

Tip: Access up to 7 years of quarterly data

All positions including Nuvation Bio held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvation Bio by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.5M 611k 8.96

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Abivax Sponsored Ads (ABVX)
Tg Therapeutics (TGTX)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)
Arrowhead Pharmaceuticals (ARWR)
Cytokinetics (CYTK)
Celcuity Inc Com Mar 20 26 $50 Call Option
Structure Therapeutics Sponsored Ads (GPCR)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Figure Technology Solutions Com Cl A (FIGR)

View all positions for ACT Capital Management

Top funds holding Nuvation Bio

FMR
Decheng Capital
BlackRock
Vanguard Group
Omega Fund Management
Laurion Capital Management
State Street Corporation
Geode Capital Management
Millennium Management
Nuveen
Tang Capital Management
Abrams Capital Management
Redmile Group
Citadel Advisors
Caption Management

View all funds holding Nuvation Bio